t-Bu-QuinoxP* ligand: Applications in asymmetric Pd-catalyzed allylic substitution and Ru-catalyzed hydrogenation

Journal of Organic Chemistry

Volumn 72, Issue 19, 2007, Pages 7413-7416

  Imamoto, Tsuneo ^a   Nishimura, Miwako ^a   Koide, Aya ^a   Yoshida, Kazuhiro ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYST ACTIVITY; CHIRALITY; HYDROGENATION; KETONES; PALLADIUM COMPOUNDS; SUBSTITUTION REACTIONS;

ASYMMETRIC ALLYLIC SUBSTITUTION; ASYMMETRIC INDUCTION; CHIRAL LIGANDS;

LIGANDS;

LIGAND; PALLADIUM; RUTHENIUM;

ALLYLATION; ARTICLE; ASYMMETRIC CATALYSIS; ASYMMETRIC SYNTHESIS; CRYSTAL STRUCTURE; HYDROGENATION; X RAY CRYSTALLOGRAPHY;

EID: 34548735265     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo071192k     Document Type: Article

References (36)

1. For representative reviews, see: (a) Tang, W.; Zhang, X. Chem. Rev. 2003, 103, 3029-3069.
2. (b) Crépy, K. V. L.; Imamoto, T. Top. Curr. Chem. 2003, 229, 1-40.
3. (c) Guiry, P. J.; Saunders, C. P. Adv. Synth. Catal. 2004, 346, 497-537.
4. For recent representative examples, see: (a) Tang, W.; Zhang, X. Angew. Chem., Int. Ed. 2002, 41, 1612-1614.
5. (b) Ostermeier, M.; Priess, J.; Helmchen, G. Angew. Chem., Int. Ed. 2002, 41, 612-614.
6. (c) Hu, A.-G.; Fu, Y.; Xie, J. H.; Zhou, H.; Wang, L. X.; Zhou, Q. L. Angew. Chem., Int. Ed. 2002, 41, 2348-2350.
7. (d) Tang, W.; Wang, W.; Zhang, X. Angew. Chem., Int. Ed. 2003, 42, 943-946.
8. (e) Hoge, G.; Wu, H.-P.; Kissel, W. S.; Pflum, D. A.; Greene, D. J.; Bao, J. J. Am. Chem. Soc 2004, 126, 5966-5977.
9. (f) Fu, Y.; Hou, G. H.; Xie, J. H.; Xing, L.; Wang, L. X.; Zhou, Q. L. J. Org. Chem. 2004, 69, 8157-8160.
10. (g) Wu, S.; Zhang, W.; Zhang, Z.; Zhang, X. Org. Lett. 2004, 6, 3565-3567.
11. (h) Hu, X. P.; Zheng, Z. Org. Lett. 2004, 6, 3585-3588.
12. (i) Imamoto, T.; Oohara, N.; Takahashi, H. Synthesis 2004, 1353-1358.
13. (j) Imamoto, T.; Crepy, K. V. L.; Katagiri, K. Tetrahedron: Asymmetry 2004, 15, 2213-2218.
14. (k) Cheng, X.; Zhang, Q.; Xie, J.-H.; Wang, L. X.; Zhou, Q. L. Angew. Chem., Int. Ed. 2005, 44, 1118-1121.
15. (l) Pàmies, O.; Diéguez, M.; Claver, C. J. Am. Chem. Soc. 2005, 127, 3646-3647.
16. (m) Takahashi, Y.; Yamamoto, Y.; Katagiri, K.; Danjo, H.; Yamaguchi, K.; Imamoto, T. J. Org. Chem. 2005, 70, 9009-9012.
17. (n) Yan, Y.; Zhang, X. J. Am. Chem. Soc. 2006, 128, 7198-7202.
18. (o) Zhu, S. F.; Xie, J. B.; Zhang, Y. Z.; Li, S.; Zhou, Q. L. J. Am. Chem. Soc 2006, 128, 12886-12891.
19. (p) Imamoto, T.; Yashio, K.; Crépy, K. V. L.; Katagiri, K.; Takahashi, H.; Kouchi, M.; Gridnev, I. D. Organometallics 2006, 25, 908-914.
20. Imamoto, T.; Watanabe, J.; Wada, Y.; Masuda, H.; Yamada, H.; Tsuruta, H.; Matsukawa, S.; Yamaguchi, K. J. Am. Chem. Soc. 1998, 120, 1635-1636.
21. Yamanoi, Y.; Imamoto, T. J. Org. Chem. 1999, 64, 2988-2989.
22. Gridnev, I. D.; Yamanoi, Y.; Higashi, N.; Tsuruta, H.; Yasutake, M.; Imamoto, T. Adv. Synth. Catal. 2001, 343, 118-136.
23. Imamoto, T.; Sugita, K.; Yoshida, K. J. Am. Chem. Soc. 2005, 127, 11934-11935.
24. Both enantiomers of t-Bu-QuinoxP* are commercially available from Aldrich Chemical Company. Imamoto, T.; Sugita, K.; Yoshida, K. U.S. Patent 2007021610, 2007; Imamoto, T.; Sugita, K.; Yoshida, K. JP Patent, 2007056007, 2007.
25. Imamoto, T.; Itoh, T.; Yamanoi, Y.; Narui, R.; Yoshida, K. Tetrahedron: Asymmetry 2006, 17, 560-565.
26. (a) Trost, B. M.; Van Vranken, D. L. Chem. Rev. 1996, 96, 395-422.
27. (b) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103, 2921-2944.
28. Ohkuma, T.; Noyori, R. In Handbook of Homogeneous Hydrogenation; de Vries, J. G., Elsevier, C. J., Eds.; Wiley-VCH: Weinheim, Germany, 2007; Vol. 3, pp 1105-1163.
29. The unit cell contained two Pd complexes and two dichloromethane molecules. One of the Pd complexes and the dichloromethane molecules are omited in Figure 1 and Table 1; CCDC 649473 for the compounds contains supplementary crystallographic data. The data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from The Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 IEZ, UK; fax: (+44) 1223-336-033; e-mail: deposit@ccdc.cam.ac.uk).
30. (a) Steffen, W. L.; Palenik, G. J. Inorg. Chem. 1976, 15, 2432-2439.
31. (b) Ozawa, F.; Kubo, A.; Matsumoto, Y.; Hayashi, T. Organometallics 1993, 12, 4188-4196.
32. 2-symmetric ligands are not so effective for Pd-catalyzed asymmetric allylic substitution as expected from their wide range of success in other catalytic asymmetric reactions; see ref 9.
33. Nemoto, T.; Masuda, T.; Akimoto, Y.; Fukuyama, T.; Hamada, Y. Org. Lett. 2005, 7, 4447-4450.
34. Byproducts were observed only in the reaction of 3-oxo-3-arylpropionic acid ethyl esters having an electron-donating group on the aromatic ring. We found that the byproducts were formed by the reaction of produced alcohol 6 with EtOH in the presence of the t-Bu-QuinoxP*-Ru complex under the same conditions as those for the hydrogenation. Further, 6c also reacted with MeOH to give the 3-methoxy-3-(4′-methoxyphenyl)propionic acid ethyl ester. In the absence of hydrogen or Ru complex, no reaction occurred between 6c and alcohol.
35. It is noted that hydrogenation product 6g (99.8% ee) is the key intermediate for epinephrine. See: Singer, R. A.; Carreira, E. M. Tetrahedron Lett. 1997, 38, 927-930.
36. It is noted that hydrogenation product 6i (99.2% ee) is the key intermediate for carnitine. See: Kitamura, M.; Ohkuma, T.; Takaya, H.; Noyori, R. Tetrahedron Lett. 1988, 29, 1555-1556.